Home-based AI exercise program for people with multiple sclerosis
Tests an AI-guided home exercise system on walking in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
Key facts
- Where
- Cagliari, ItalySee the site
- Phase
- Phase 2
Where in Italy
- University of CagliariCagliari, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Danish Multiple Sclerosis Hospitals
- Trial code
- NCT07310914
- Record updated
- 30 December 2025
- Original description
The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.Read full original descriptionShow less
Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.
Inclusion: Definite diagnosis of MS according to the McDonald criteria (both relapse-remitting and progressive); Expanded Disability Status Scale (EDSS) score of 2.5 to 6.5 or Patient Determined Disability Score (PDDS) of 2 to 6, indicating preservation of at least some ambulatory function, that is, the ability to walk 20 meters or more, independently, with or without the use of an assistive device; Willingness to travel to the local study site for the evaluation sessions,; Internet platform availability.
Exclusion: comorbidities hindering participation in the study; Individuals who have had a documented relapse and/or corticoid treatment during the past three months will be excluded,; Individuals with severe cognitive deficits who cannot follow simple instructions and/or consent.